These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16871452)

  • 1. American Society of Clinical Oncology--42nd annual meeting. 2-6 June 2006, Atlanta, GA, USA.
    Chan D; Cleverley J; Searle B
    IDrugs; 2006 Aug; 9(8):517-9. PubMed ID: 16871452
    [No Abstract]   [Full Text] [Related]  

  • 2. American Society of Clinical Oncology--42nd annual meeting. Epigenetic targeting and reports on cancer-related therapies. 2-6 June 2006, Atlanta, GA, USA.
    Searle B
    IDrugs; 2006 Aug; 9(8):526-8. PubMed ID: 16871455
    [No Abstract]   [Full Text] [Related]  

  • 3. 42nd annual meeting of the American Society of Clinical Oncology June 2006, Atlanta, GA.
    Schwab C; Shivakumar L
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):16-24. PubMed ID: 16879765
    [No Abstract]   [Full Text] [Related]  

  • 4. American Association for Cancer Research--97th annual meeting.
    Kondo Y; Kondo S
    IDrugs; 2006 Jun; 9(6):409-11. PubMed ID: 16752309
    [No Abstract]   [Full Text] [Related]  

  • 5. American Society of Hematology--48th Annual Meeting and Exposition. Updates on hematological therapies. 9-12 December 2006 Orlando, FL, USA.
    Walker K
    IDrugs; 2007 Feb; 10(2):78-80. PubMed ID: 17285452
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness of 17DMAG, a geldanamycin derivative, in murine acute myeloid leukemia.
    Panarsky R; Reichert F; Ben-Ishay Z
    Acta Haematol; 2009; 121(1):32-6. PubMed ID: 19332984
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein chaperones as anticancer therapy targets.
    Sausville E
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):92-3. PubMed ID: 16163168
    [No Abstract]   [Full Text] [Related]  

  • 8. American Society of Clinical Oncology--42nd annual meeting. Ovarian cancer, solid tumors, neuroendocrine tumors and lymphoma. 2-6 June 2006, Atlanta, GA, USA.
    Searle B; Chan D
    IDrugs; 2006 Aug; 9(8):529-31. PubMed ID: 16871456
    [No Abstract]   [Full Text] [Related]  

  • 9. American Society of Clinical Oncology--42nd annual meeting. Current approaches to lung cancer therapy. 2-6 June 2006, Atlanta, GA, USA.
    Chan D; Cleverley J
    IDrugs; 2006 Aug; 9(8):523-5. PubMed ID: 16871454
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on "Lowpenetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras" by Park et al.
    Harbour JW
    Cell Cycle; 2008 Aug; 7(15):2276-7. PubMed ID: 18682685
    [No Abstract]   [Full Text] [Related]  

  • 11. Highlights from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA, June 2006.
    Clin Breast Cancer; 2006 Oct; 7(4):306-14. PubMed ID: 17092397
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights from the 42nd annual meeting of the American Society of Clinical Oncology Atlanta, GA, USA, 2-6 June 2006.
    Puglisi F; Andreetta C; Fasola G
    Expert Opin Pharmacother; 2006 Nov; 7(16):2309-18. PubMed ID: 17059386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geldanamycin accelerated peripheral nerve regeneration in comparison to FK-506 in vivo.
    Sun HH; Saheb-Al-Zamani M; Yan Y; Hunter DA; Mackinnon SE; Johnson PJ
    Neuroscience; 2012 Oct; 223():114-23. PubMed ID: 22835622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA; June 2-6, 2006.
    Reddy GK; Tyagi P
    Clin Genitourin Cancer; 2006 Jun; 5(1):18-22. PubMed ID: 16859574
    [No Abstract]   [Full Text] [Related]  

  • 15. Geldanamycin protects rat brain through overexpression of HSP70 and reducing brain edema after cerebral focal ischemia.
    Kwon HM; Kim Y; Yang SI; Kim YJ; Lee SH; Yoon BW
    Neurol Res; 2008 Sep; 30(7):740-5. PubMed ID: 18534054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology--42nd annual meeting. Poster presentations on leukemia and cytotoxic chemotherapy. 2-6 June 2006, Atlanta, GA, USA.
    Cleverley J
    IDrugs; 2006 Aug; 9(8):520-2. PubMed ID: 16871453
    [No Abstract]   [Full Text] [Related]  

  • 17. Autophagy inhibition sensitizes multiple myeloma cells to 17-dimethylaminoethylamino-17-demethoxygeldanamycin-induced apoptosis.
    Palacios C; Martín-Pérez R; López-Pérez AI; Pandiella A; López-Rivas A
    Leuk Res; 2010 Nov; 34(11):1533-8. PubMed ID: 20667592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent.
    Hanson BE; Vesole DH
    Expert Opin Investig Drugs; 2009 Sep; 18(9):1375-83. PubMed ID: 19642950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17-ABAG, a novel geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition.
    Lin Z; Peng R; Li Z; Wang Y; Lu C; Shen Y; Wang J; Shi G
    Int J Mol Med; 2015 Aug; 36(2):424-32. PubMed ID: 26059743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geldanamycin Reduces Aβ-Associated Anxiety and Depression, Concurrent with Autophagy Provocation.
    Zare N; Khalifeh S; Khodagholi F; Shahamati SZ; Motamedi F; Maghsoudi N
    J Mol Neurosci; 2015 Nov; 57(3):317-24. PubMed ID: 26208597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.